Beijing Union Pharmaceutical Factory Ltd: Clinical Trials

6 trials sponsored by Beijing Union Pharmaceutical Factory Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 2 recruiting, 1 completed, 1 unknown. 3 Phase 3, 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Recruiting 2, Unknown 1
Phase 12Not yet recruiting 2
Phase 21Completed 1

Follow Beijing Union Pharmaceutical Factory Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study on the Drug Interaction Between Buagafuran and Voriconazole
Buagafuran, Voriconazole - Drug Drug Interaction (DDI)
Phase 1Not yet recruitingBeijing Union Pharmaceutical Factory Ltd182026-04-012026-03-09
Pharmacokinetic Study of Buagafuran Capsules in Participants With Hepatic Impairment and Normal Hepatic Function
Buagafuran - Generalized Anxiety Disorder
Phase 1Not yet recruitingBeijing Union Pharmaceutical Factory Ltd242026-03-012026-03-10
Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD
Buagafuran capsules, 15mg/ capsule, Buagafuran capsules mimic, 0mg/ capsule - Generalized Anxiety Disorder
Phase 3RecruitingBeijing Union Pharmaceutical Factory Ltd5042023-07-252024-02-06
Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD
Buagafuran capsules, 15mg/ capsule, Buspirone tablets, 5mg/ tablet, Buagafuran capsules mimic, 0mg/ capsule - Generalized Anxiety Disorder
Phase 3RecruitingBeijing Union Pharmaceutical Factory Ltd4102023-07-242024-02-06
The Multi-Center, Randomized, Double-blind, Positive Controlled Clinical Trial of Bicyclol in the Treatment of Acute DILI
bicyclol, 25mg/ tablet, polyene phosphatidylcholine capsules, 228mg/ particle. - Drug-Induced Acute Liver Injury
Phase 3UnknownDrug Induced Liver Disease Study Group3602021-12-202022-08-04
The Multi Center, Randomized, Double-blind, Positive Controlled Study of Bicyclol in the Treatment of Acute DILI
bicyclol tablet 25mg, bicyclol tablet 50mg, polyene phosphatidylcholine capsule 456mg - Drug-Induced Acute Liver Injury
Phase 2CompletedDrug Induced Liver Disease Study Group2442017-08-182020-04-28

Conditions studied

Generalized Anxiety Disorder (3)  ·  Chemical and Drug Induced Liver Injury (2)

Interventions

buagafuran (4)  ·  Tablets (2)  ·  bicyclol (2)  ·  polyene phosphatidylcholine (2)  ·  tebufenozide (2)  ·  Buspirone (1)  ·  Voriconazole (1)

Countries

China (6)

Top investigators

Chengwei Chen (2)  ·  Hong Zhang (2)  ·  Yimin Mao (2)

Results publications

PMID 35567757